Acute heart failure treatment

James D Kirk; Gerasimos Filippatos; Mihai Gheorghiade; Peter S. Pang; Phillip Levy; Ezra A Amsterdam; W. Frank Peacock; Gregg C. Fonarow

doi:10.1097/HPC.0b013e318177df37

Acute heart failure treatment

James D Kirk, Gerasimos Filippatos, Mihai Gheorghiade, Peter S. Pang, Phillip Levy, Ezra A Amsterdam, W. Frank Peacock, Gregg C. Fonarow

Research output: Contribution to journal › Article

2 Scopus citations

Abstract

Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.

Original language	English (US)
Pages (from-to)	103-110
Number of pages	8
Journal	Critical Pathways in Cardiology
Volume	7
Issue number	2
DOIs	https://doi.org/10.1097/HPC.0b013e318177df37
State	Published - Jun 2008
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Cite this

Kirk, J. D., Filippatos, G., Gheorghiade, M., Pang, P. S., Levy, P., Amsterdam, E. A., Peacock, W. F., & Fonarow, G. C. (2008). Acute heart failure treatment. Critical Pathways in Cardiology, 7(2), 103-110. https://doi.org/10.1097/HPC.0b013e318177df37

@article{581f82a516a04d0aa6d2fa92e7040e4a,

title = "Acute heart failure treatment",

abstract = "Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.",

author = "Kirk, {James D} and Gerasimos Filippatos and Mihai Gheorghiade and Pang, {Peter S.} and Phillip Levy and Amsterdam, {Ezra A} and Peacock, {W. Frank} and Fonarow, {Gregg C.}",

year = "2008",

month = jun

doi = "10.1097/HPC.0b013e318177df37",

language = "English (US)",

volume = "7",

pages = "103--110",

journal = "Critical Pathways in Cardiology",

issn = "1535-282X",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Acute heart failure treatment

AU - Kirk, James D

AU - Filippatos, Gerasimos

AU - Gheorghiade, Mihai

AU - Pang, Peter S.

AU - Levy, Phillip

AU - Amsterdam, Ezra A

AU - Peacock, W. Frank

AU - Fonarow, Gregg C.

PY - 2008/6

Y1 - 2008/6

N2 - Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.

AB - Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.

UR - http://www.scopus.com/inward/record.url?scp=67650118200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650118200&partnerID=8YFLogxK

U2 - 10.1097/HPC.0b013e318177df37

DO - 10.1097/HPC.0b013e318177df37

M3 - Article

AN - SCOPUS:67650118200

VL - 7

SP - 103

EP - 110

JO - Critical Pathways in Cardiology

JF - Critical Pathways in Cardiology

SN - 1535-282X

IS - 2

ER -

Access to Document

10.1097/HPC.0b013e318177df37